Zifeng Deng

551 total citations
15 papers, 223 citations indexed

About

Zifeng Deng is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Zifeng Deng has authored 15 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in Zifeng Deng's work include MicroRNA in disease regulation (4 papers), Inflammatory Bowel Disease (3 papers) and Ubiquitin and proteasome pathways (3 papers). Zifeng Deng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Inflammatory Bowel Disease (3 papers) and Ubiquitin and proteasome pathways (3 papers). Zifeng Deng collaborates with scholars based in China, United States and Philippines. Zifeng Deng's co-authors include Jinyang Li, Huixiang Ma, David T. Rubin, Joel Pekow, Katherine Meckel, Marc Bissonnette, John Hart, Urszula Dougherty, Reba Mustafi and Li Sun and has published in prestigious journals such as Clinical Cancer Research, American Journal of Ophthalmology and Toxicology and Applied Pharmacology.

In The Last Decade

Zifeng Deng

13 papers receiving 221 citations

Peers

Zifeng Deng
Comparison fields: 5 of 48
  • Molecular Biology 102
  • Cancer Research 80
  • Public Health, Environmental and Occupational Health 64
  • Radiology, Nuclear Medicine and Imaging 42
  • Ophthalmology 33
Replace Tao Guan with:
Tao Guan China
Charles B. Trelford Canada
Shusai Yamada Japan
Jianxin Guo China
Jason Tasoulas Greece
Zhen‐Shan Yang China
Nenad Kunac Croatia
Lynn McCallum United Kingdom
Yuqian Zhou China
Tao Guan China View profile →
Citations per field, relative to Zifeng Deng
Zifeng Deng · 1×
Citations per year, relative to Zifeng Deng
Zifeng Deng · 1×

Countries citing papers authored by Zifeng Deng

Since Specialization
Citations

This map shows the geographic impact of Zifeng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifeng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifeng Deng more than expected).

Fields of papers citing papers by Zifeng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zifeng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifeng Deng. The network helps show where Zifeng Deng may publish in the future.

Co-authorship network of co-authors of Zifeng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Zifeng Deng. A scholar is included among the top collaborators of Zifeng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifeng Deng. Zifeng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Work Indexed citations
1 0
2 3
3 0
4 3
5 4
6 2
7 9
8 4
9 16
10 4
11 9
12 72
13 23
14 37
15 37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026